Herpes Simplex Epithelial Keratitis and Contact lens: A Case Report
DOI:
https://doi.org/10.15353/cjo.v86i3.5612Keywords:
Herpes simplex keratitis, Contact Lenses, Herpes simplex epithelial keratitis, Langerhans’s cellsAbstract
Herpes simplex virus keratitis is an ocular infection arising from the reactivation of HSV; if not promptly addressed, it can lead to diminished visual acuity and potential blindness in the affected eye. The sight-threatening aspects of this infection are primarily associated with the development of scarring and opacity. A 22-year-old woman, an otherwise healthy contact lens wearer, sought medical attention with complaints of painful, red, and photophobic eyes. Upon examination, a dendritic ulcer was observed on the right eye, accompanied by toxic keratopathy in both eyes. The treatment regimen that was implemented consisted of valacyclovir and ocular lubrication. The disruption of the host's natural immunological barriers, exacerbated by suboptimal contact lens handling, paved the way for subsequent dendritic ulceration. This occurrence was instigated by the reactivation of the herpes simplex virus, underscoring the critical importance of timely intervention.
References
1. Grinde B. Herpesviruses: latency and reactivation–viral strategies and host response. J oral microbiol. 2013;5(1):22766. doi:10.3402/jom.v5i0.22766
2. Fatahzadeh M, Schwartz RA. Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management. J Am Acad Dermatol. Nov 2007;57(5):737-63; quiz 764-6. doi:10.1016/j.jaad.2007.06.027
3. AlMukdad S, Harfouche M, Farooqui US, Aldos L, Abu-Raddad LJ. Epidemiology of herpes simplex virus type 1 in Canada: systematic review, meta-analyses, and meta-regressions. Front Public Health. 2023;11:1118249. doi:10.3389/fpubh.2023.1118249
4. AlMukdad S, Farooqui US, Harfouche M, Aldos L, Abu-Raddad LJ. Epidemiology of Herpes Simplex Virus Type 2 in Canada, Australia, and New Zealand: Systematic Review, Meta-Analyses, and Meta-Regressions. Sex Transm Dis. Jun 1 2022;49(6):403-413. doi:10.1097/OLQ.0000000000001612
5. Tran T, Druce J, Catton M, Kelly H, Birch C. Changing epidemiology of genital herpes simplex virus infection in Melbourne, Australia, between 1980 and 2003. Sex transm infect. 2004;80(4):277-279.
6. Reynaud C, Rousseau A, Kaswin G, M'Garrech M, Barreau E, Labetoulle M. Persistent Impairment of Quality of Life in Patients with Herpes Simplex Keratitis. Ophthalmol. Feb 2017;124(2):160-169. doi:10.1016/j.ophtha.2016.10.001
7. Stoeger T, Adler H. “Novel” triggers of herpesvirus reactivation and their potential health relevance. Front Microbiol. 2019;9:3207. doi:10.3389/fmicb.2018.03207
8. Efron N, Jones L, Bron AJ, et al. The TFOS International Workshop on Contact Lens Discomfort: report of the contact lens interactions with the ocular surface and adnexa subcommittee. Invest Ophthalmol Vis Sci. Oct 18 2013;54(11):TFOS98-TFOS122. doi:10.1167/iovs.13-13187
9. Ayoade F, Kumar S. Varicella-Zoster Virus (Chickenpox). In: StatPearls, ed. StatPearls [Internet]. StatPearls Publishing; 2024 Jan.
10. Zerboni L, Sen N, Oliver SL, Arvin AM. Molecular mechanisms of varicella zoster virus pathogenesis. Nat Rev Microbiol. Mar 2014;12(3):197-210. doi:10.1038/nrmicro3215
11. Gershon AA, Gershon MD, Breuer J, Levin MJ, Oaklander AL, Griffiths PD. Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol. May 2010;48 Suppl 1(Suppl 1):S2-7. doi:10.1016/S1386-6532(10)70002-0
12. Kennedy PGE. The Spectrum of Neurological Manifestations of Varicella-Zoster Virus Reactivation. Viruses. Jul 30 2023;15(8)doi:10.3390/v15081663
13. Minor M, Payne E. Herpes Zoster Ophthalmicus. In: StatPearls, ed. StatPearls [Internet]. StatPearls Publishing; 2024 Jan.
14. Nagel MA, Gilden D. Complications of varicella zoster virus reactivation. Curr Treat Options Neurol. Aug 2013;15(4):439-53. doi:10.1007/s11940-013-0246-5
15. Kalogeropoulos CD, Bassukas ID, Moschos MM, Tabbara KF. Eye and Periocular Skin Involvement in Herpes Zoster Infection. Med Hypothesis Discov Innov Ophthalmol. Winter 2015;4(4):142-156.
16. Schmader KE, Dworkin RH. The epidemiology and natural history of herpes zoster and postherpetic neuralgia. Herpes Zoster: Postherpetic Neuralgia and Other Complications: Focus on Treatment and Prevention. 2017:25-44.
17. Jackson AC. Viral infections of the human nervous system. Springer Science & Business Media; 2012.
18. Borkar DS, Tham VM, Esterberg E, et al. Incidence of herpes zoster ophthalmicus: results from the Pacific Ocular Inflammation Study. Ophthalmol. Mar 2013;120(3):451-456. doi:10.1016/j.ophtha.2012.09.007
19. Kanski JJ, Bowling B. Kanski's clinical ophthalmology e-book: a systematic approach. Elsevier Health Sciences; 2015.
20. Liesegang TJ. Contact lens-related microbial keratitis: Part I: Epidemiology. Cornea. Mar 1997;16(2):125-31.
21. Hatami H, Ghaffari Jolfayi A, Ebrahimi A, Golmohammadi S, Zangiabadian M, Nasiri MJ. Contact Lens Associated Bacterial Keratitis: Common Organisms, Antibiotic Therapy, and Global Resistance Trends: A Systematic Review. Front Ophthalmol. 2021;1:759271.
22. Musa F, Tailor R, Gao A, Hutley E, Rauz S, Scott RA. Contact lens-related microbial keratitis in deployed British military personnel. Br J Ophthalmol. Aug 2010;94(8):988-93. doi:10.1136/bjo.2009.161430
23. Gurnani B, Kaur K. Bacterial Keratitis. StatPearls [Internet]. StatPearls Publishing; 2023.
24. Lakhundi S, Siddiqui R, Khan NA. Pathogenesis of microbial keratitis. Microb Pathog. Mar 2017;104:97-109. doi:10.1016/j.micpath.2016.12.013
25. Szentmáry N, Daas L, Shi L, et al. Acanthamoeba keratitis–Clinical signs, differential diagnosis and treatment. J curr ophthalmol. 2019;31(1):16-23.
26. de Lacerda AG, Lira M. Acanthamoeba keratitis: a review of biology, pathophysiology and epidemiology. Ophthal Physiol Opt. Jan 2021;41(1):116-135. doi:10.1111/opo.12752
27. Ibrahim YW, Boase DL, Cree IA. How could contact lens wearers be at risk of Acanthamoeba infection? A review. J Optom. 2009;2(2):60-66.
28. de Paiva CS, St Leger AJ, Caspi RR. Mucosal immunology of the ocular surface. Mucosal Immunol. Jun 2022;15(6):1143-1157. doi:10.1038/s41385-022-00551-6
29. Somani SN, Ronquillo Y, Moshirfar M. Acanthamoeba Keratitis. StatPearls. 2023.
30. Azher TN, Yin XT, Tajfirouz D, Huang AJ, Stuart PM. Herpes simplex keratitis: challenges in diagnosis and clinical management. Clin Ophthalmol. 2017;11:185-191. doi:10.2147/OPTH.S80475
31. Liesegang TJ. Epidemiology and natural history of ocular herpes simplex virus infection in Rochester, Minnesota, 1950-1982. Trans Am Ophthalmol Soc. 1988;86:688-724.
32. Whitley R, Kimberlin D, Prober C. Pathogenesis and disease. In: Arvin A, Campadelli-Fiume G, Mocarski E, eds. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge University Press; 2007:chap 32.
33. Fernandez-Obregon AC, Shah D, Howell AI, et al. Challenges in anti-infective therapy for skin conditions: part 1. Expert Rev Dermatol. 2008;3(3):367-394.
34. James C, Harfouche M, Welton NJ, et al. Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bull World Health Organ. May 1 2020;98(5):315-329. doi:10.2471/BLT.19.237149
35. Chew T, Taylor KE, Mossman KL. Innate and adaptive immune responses to herpes simplex virus. Viruses. Dec 2009;1(3):979-1002. doi:10.3390/v1030979
36. Mustafa M, Illzam E, Muniandy R, Sharifah A, Nang M, Ramesh B. Herpes simplex virus infections, Pathophysiology and Management. IOSR J dent med sci. 2016;15(07):85-91.
37. Lafferty WE, Downey L, Celum C, Wald A. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. The J infectious dis. 2000;181(4):1454-1457.
38. Ahmad B, Patel B. Herpes Simplex Keratitis. StatPearls [Internet]. StatPearls Publishing; 2023.
39. Bagga B, Kate A, Joseph J, Dave V. Herpes simplex infection of the eye: an introduction. Community Eye Health. 2020;33(108):68-70.
40. Kanukollu VM, Patel BC. Herpes simplex ophthalmicus. StatsPearls [Internet]. StatPearls Publishing; 2023 Apr 17.
41. Hill GM, Ku ES, Dwarakanathan S. Herpes simplex keratitis. Disease-a-Month. 2014;60(6):239-246.
42. Chaloulis SK, Mousteris G, Tsaousis KT. Incidence and Risk Factors of Bilateral Herpetic Keratitis: 2022 Update. Trop Med Infect Dis. Jun 7 2022;7(6)doi:10.3390/tropicalmed7060092
43. McCormick I, James C, Welton NJ, et al. Incidence of Herpes Simplex Virus Keratitis and Other Ocular Disease: Global Review and Estimates. Ophthal Epidemiol. Aug 2022;29(4):353-362. doi:10.1080/09286586.2021.1962919
44. Farhatullah S, Kaza S, Athmanathan S, Garg P, Reddy SB, Sharma S. Diagnosis of herpes simplex virus-1 keratitis using Giemsa stain, immunofluorescence assay, and polymerase chain reaction assay on corneal scrapings. Br J Ophthalmol. Jan 2004;88(1):142-4. doi:10.1136/bjo.88.1.142
45. Subhan S, Jose RJ, Duggirala A, et al. Diagnosis of herpes simplex virus-1 keratitis: comparison of Giemsa stain, immunofluorescence assay and polymerase chain reaction. Curr Eye Res. Aug-Sep 2004;29(2-3):209-13. doi:10.1080/02713680490504911
46. Cope JR, Konne NM, Jacobs DS, et al. Corneal infections associated with sleeping in contact lenses—six cases, United States, 2016–2018. Morbidity and Mortality Weekly Report. 2018;67(32):877.
47. Fleiszig SM, Kroken AR, Nieto V, et al. Contact lens-related corneal infection: Intrinsic resistance and its compromise. Prog retinal eye res. 2020;76:100804. doi:10.1016/j.preteyeres.2019.100804
48. Barba Gallardo LF, Muñoz Ortega MH, Ventura Juarez J, et al. Extended low oxygen transmissibility contact lens use induces alterations in the concentration of proinflammatory cytokines, enzymes and electrolytes in tear fluid. Exp Ther Med. 2018;15(5):4291-4297. doi:10.3892/etm.2018.5989
49. Boost M, Cho P, Wang Z. Disturbing the balance: effect of contact lens use on the ocular proteome and microbiome. Clin exp optom. 2017;100(5):459-472. doi:10.1111/cxo.12582
50. Akpek E, Gottsch J. Immune defense at the ocular surface. Eye. 2003;17(8):949-956.
51. Pearlman E, Sun Y, Roy S, et al. Host defense at the ocular surface. Internat rev immunol. 2013;32(1):4-18.
52. Liesegang TJ. Physiologic changes of the cornea with contact lens wear. CLAO J. Jan 2002;28(1):12-27.
53. Martin XY, Safran AB. Corneal hypoesthesia. Surv ophthalmol. 1988;33(1):28-40. doi:10.1016/0039-6257(88)90070-7
54. Yang AY, Chow J, Liu J. Focus: sensory biology and pain: corneal innervation and sensation: the eye and beyond. The Yale j biol med. 2018;91(1):13.
55. Lens Cleaning Solution. 2009:2. Material Safety Data Sheet. chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.mccsd.net/cms/lib/NY02208580/Centricity/Shared/Material%20Safety%20Data%20Sheets%20_MSDS_/MSDS%20Sheets_Lens_Cleaning_Solution_406_00.pdf
56. Lee J, Jun JH. Ocular chemical burn associated with gel type alcohol-based hand sanitizer: A case report. Medicine (Baltimore). Oct 22 2021;100(42):e27292. doi:10.1097/MD.0000000000027292
57. Oh JY, Yu JM, Ko JH. Analysis of ethanol effects on corneal epithelium. Invest Ophthalmol Vis Sci. Jun 4 2013;54(6):3852-6. doi:10.1167/iovs.13-11717
58. Hamrah P, Pavan-Langston D, Dana R. Herpes simplex keratitis and dendritic cells at the crossroads: lessons from the past and a view into the future. Internat ophthalmol clin. 2009;49(1):53. doi:10.1097/IIO.0b013e3181924dd8
59. Jager MJ, Atherton S, Bradley D, Streilein JW. Herpetic stromal keratitis in mice: less reversibility in the presence of Langerhans cells in the central cornea. Curr Eye Res. 1991;10 Suppl:69-73. doi:10.3109/02713689109020360
60. Alzahrani Y, Pritchard N, Efron N. Changes in corneal Langerhans cell density during the first few hours of contact lens wear. Contact Lens Ant Eye. 2016;39(4):307-310. doi:10.1016/j.clae.2016.02.008
61. Wilhelmus KR. Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis. Cochrane Database Syst Rev. Jan 9 2015;1(1):CD002898. doi:10.1002/14651858.CD002898.pub5
62. White ML, Chodosh J. Herpes simplex virus keratitis: a treatment guideline. Hoskins Center for Quality Eye Care and American Academy of Ophthalmology Website https://www.aao.org/education/clinical-statement/herpes-simplex-virus-keratitis-treatment-guideline
63. Schuster AK, Harder BC, Schlichtenbrede FC, Jarczok MN, Tesarz J. Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients. Cochrane Database Syst Rev. Nov 14 2016;11(11):CD011503. doi:10.1002/14651858.CD011503.pub2
64. Koganti R, Yadavalli T, Shukla D. Current and Emerging Therapies for Ocular Herpes Simplex Virus Type-1 Infections. Microorganisms. Oct 10 2019;7(10)doi:10.3390/microorganisms7100429
65. Tsatsos M, MacGregor C, Athanasiadis I, et al. Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents - comment. Clin Exp Ophthalmol. Dec 2017;45(9):932. doi:10.1111/ceo.12991
66. Keegan P. Data from: Summary of Review. 2015. U.S Food and Drug Administration
67. Administration USFaD. Data from: Drug Approval Package. 2010. U.S. Food and Drug Administration.
68. Shearer DR, Bourne WM. Severe ocular anterior segment ischemia after long-term trifluridine treatment for presumed herpetic keratitis. Am J Ophthalmol. Mar 15 1990;109(3):346-7. doi:10.1016/s0002-9394(14)74564-7
69. Hernandez-Camarena JC, Suh LH. Severe Anterior Segment Toxicity Associated to Long-Term Use of Topical Trifluridine. JSM Ophthalmol. 07 March 2014;2(3):1023. doi:10.47739/2333-6447/1023
70. Laboratoires Thea. Eyezirgan. Clermont-Ferrand, France2022.
71. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group. N Engl J Med. Jul 30 1998;339(5):300-6. doi:10.1056/NEJM199807303390503
72. Group HEDS. Predictors of recurrent herpes simplex virus keratitis. Cornea. 2001;20(2):123-128.
73. Mucci JJ, Utz VM, Galor A, Feuer W, Jeng BH. Recurrence rates of herpes simplex virus keratitis in contact lens and non-contact lens wearers. Eye contact lens. 2009;35(4):185-187. doi:10.1097/ICL.0b013e3181a9d788
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Ziqing Li
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
